Coronary artery disease, lipid disorders and genetic polymorphisms

Area of Science:

• Genetics
• Cardiovascular Medicine
• Molecular Biology

Background:

• Coronary artery disease (CAD) is a leading cause of death globally, strongly linked to lipid transport disorders.
• High-density lipoproteins (HDL) and their major protein, apolipoprotein A-I (Apo A-I), are crucial for cholesterol efflux, with lower levels associated with increased CAD risk.
• Genetic factors significantly influence lipid metabolism and CAD development.

Purpose of the Study:

• To investigate genetic variations in the apolipoprotein A-I (Apo A-I) gene.
• To identify genetic markers associated with premature CAD and familial hypoalphalipoproteinemia.
• To explore the utility of Apo A-I gene polymorphisms as predictors of CAD risk.

Main Methods:

• Characterization of the human Apo A-I gene locus on chromosome 11.
• Application of molecular genetic techniques, including restriction fragment length polymorphism (RFLP) analysis.
• Identification of a polymorphic Pst I restriction site flanking the 3' end of the Apo A-I gene.

Main Results:

• The human Apo A-I gene was found to be adjacent to apolipoprotein C-III and A-IV genes.
• A polymorphic Pst I restriction-endonuclease site was identified near the 3' end of the Apo A-I gene.
• This polymorphism provides a tool for genetic association studies related to CAD.

Conclusions:

• The identified Apo A-I gene polymorphism is a valuable marker for genetic studies.
• Further research can explore the association of this genetic variation with clinical phenotypes like premature CAD.
• Understanding genetic contributions to lipid metabolism can improve CAD risk assessment and management.